▁Introduction 10.375
: 6.51953125
<0x0A> 3.98046875
P 4.65625
rem 4.5546875
ature 3.052734375
▁men 6.78125
op 0.127685546875
ause 0.0088043212890625
▁in 3.55078125
▁middle 4.13671875
- 1.087890625
aged 0.10809326171875
▁women 0.20654296875
▁with 3.55859375
▁ob 6.01171875
es 0.501953125
ity 0.00023829936981201172
▁and 1.9853515625
▁a 3.748046875
▁pre 5.8671875
dis 0.9873046875
position 0.15283203125
▁to 0.29833984375
▁breast 3.69140625
▁cancer 0.04296875
▁pos 8.796875
es 0.01235198974609375
▁unique 4.140625
▁challeng 0.59814453125
es 0.00041556358337402344
▁for 1.279296875
▁health 2.521484375
care 1.037109375
▁prov 0.50244140625
iders 0.00016200542449951172
. 0.77587890625
▁This 3.52734375
▁ess 8.4609375
ay 0.0037746429443359375
▁a 3.142578125
ims 0.002780914306640625
▁to 0.0303497314453125
▁assess 4.9765625
▁the 0.42578125
▁potential 3.5390625
▁ris 2.80078125
ks 0.0003123283386230469
▁and 0.7880859375
▁benefits 0.53076171875
▁of 0.192626953125
▁util 7.25390625
izing 0.266357421875
▁Met 10.265625
op 3.505859375
rol 0.0059356689453125
ol 0.0017547607421875
▁as 2.955078125
▁an 1.416015625
▁alternative 2.505859375
▁to 0.98583984375
▁Nor 7.59765625
vas 4.1953125
c 0.0015306472778320312
▁for 1.3515625
▁alle 6.73828125
vi 0.09942626953125
ating 0.006099700927734375
▁such 6.078125
▁sympt 1.064453125
oms 0.013580322265625
. 0.57470703125
▁Furthermore 4.5859375
, 0.03167724609375
▁it 1.474609375
▁del 5.94140625
ves 1.1240234375
▁into 0.1588134765625
▁the 0.288330078125
▁important 6.58203125
▁roles 4.71875
▁of 0.8486328125
▁di 4.7265625
et 0.6484375
▁and 0.97705078125
▁sm 8.2421875
oking 0.006114959716796875
▁within 7.34375
▁the 0.5947265625
▁compreh 7.9921875
ensive 0.1600341796875
▁treatment 2.0078125
▁plan 1.8984375
. 1.48046875
<0x0A> 1.001953125
P 2.73046875
ot 4.58203125
ential 0.031524658203125
▁Ris 0.88720703125
ks 6.663799285888672e-05
▁and 1.025390625
▁Ben 0.07147216796875
ef 6.890296936035156e-05
its 0.0024585723876953125
: 3.4609375
▁Met 2.53125
op 0.0926513671875
rol 0.0013875961303710938
ol 0.0003654956817626953
▁vs 2.41796875
. 0.65966796875
▁Nor 0.148681640625
vas 0.0106353759765625
c 0.00092315673828125
<0x0A> 0.470703125
Met 2.251953125
op 0.0175933837890625
rol 0.000514984130859375
ol 0.0001957416534423828
▁and 3.353515625
▁Nor 0.242919921875
vas 0.0015439987182617188
c 0.00027632713317871094
▁are 0.791015625
▁both 1.3701171875
▁commonly 3.87109375
▁pres 0.50244140625
cribed 0.00043845176696777344
▁medic 1.8955078125
ations 0.052642822265625
, 3.033203125
▁but 1.802734375
▁each 2.91015625
▁car 3.27734375
ries 0.0021877288818359375
▁distinct 3.341796875
▁ris 0.6640625
ks 0.00012373924255371094
▁and 0.40673828125
▁benefits 0.127197265625
▁when 3.818359375
▁used 0.806640625
▁to 1.04296875
▁address 3.921875
▁the 1.564453125
▁sympt 0.54248046875
oms 0.007659912109375
▁of 0.09503173828125
▁prem 0.85986328125
ature 0.004878997802734375
▁men 0.05206298828125
op 0.0021495819091796875
ause 0.00439453125
▁in 1.1884765625
▁middle 0.76318359375
- 0.042999267578125
aged 0.00726318359375
▁women 0.0404052734375
▁with 0.8076171875
▁ob 0.41064453125
es 0.0007524490356445312
ity 2.9802322387695312e-05
▁and 0.248291015625
▁a 0.11785888671875
▁pre 0.0213623046875
dis 0.00254058837890625
position 0.0009207725524902344
▁to 0.035888671875
▁breast 0.0174102783203125
▁cancer 0.004581451416015625
. 0.042327880859375
<0x0A> 1.2431640625
Met 1.203125
op 0.01261138916015625
rol 0.00030994415283203125
ol 7.355213165283203e-05
, 2.609375
▁a 1.423828125
▁beta 0.763671875
- 0.39453125
block 0.19580078125
er 0.138671875
, 0.33056640625
▁can 3.810546875
▁help 3.05859375
▁manage 3.361328125
▁sympt 1.8876953125
oms 0.00635528564453125
▁such 2.208984375
▁as 0.00421142578125
▁hot 1.2392578125
▁flash 0.1416015625
es 0.002063751220703125
▁and 1.314453125
▁pal 4.9609375
pit 0.031097412109375
ations 0.00010526180267333984
. 1.431640625
▁While 4.359375
▁studies 6.16796875
▁have 0.4267578125
▁suggested 2.85546875
▁that 0.443359375
▁beta 3.46484375
- 0.025482177734375
block 0.006610870361328125
ers 0.031402587890625
▁may 0.78076171875
▁slightly 6.78515625
▁increase 1.7197265625
▁the 0.295654296875
▁risk 0.10772705078125
▁of 0.10906982421875
▁breast 1.9814453125
▁cancer 0.01470184326171875
, 0.705078125
▁the 1.60546875
▁specific 6.17578125
▁connection 5.7734375
▁to 2.921875
▁Met 2.107421875
op 0.0036869049072265625
rol 0.00023889541625976562
ol 0.00010442733764648438
▁is 1.2119140625
▁incon 3.458984375
clus 0.0009670257568359375
ive 0.00018131732940673828
. 0.223876953125
▁Add 8.046875
itional 0.02362060546875
▁potential 4.03515625
▁ris 0.52880859375
ks 3.0279159545898438e-05
▁associated 1.9609375
▁with 0.003459930419921875
▁Met 0.453857421875
op 0.001953125
rol 0.0007109642028808594
ol 0.00017082691192626953
▁usage 6.44140625
▁include 0.19384765625
▁fat 6.46484375
igue 0.1614990234375
, 0.211181640625
▁d 1.6650390625
izz 0.07843017578125
iness 0.0006427764892578125
, 0.059051513671875
▁and 0.7822265625
▁ere 5.0078125
ct 0.021209716796875
ile 8.07046890258789e-05
▁d 0.01113128662109375
ys 3.6597251892089844e-05
function 0.001529693603515625
. 0.18603515625
▁On 4.28515625
▁the 0.03851318359375
▁other 0.184814453125
▁hand 0.0169677734375
, 0.0016393661499023438
▁potential 5.875
▁benefits 0.474609375
▁lie 10.015625
▁in 0.126953125
▁its 1.625
▁ability 0.5390625
▁to 0.0026912689208984375
▁reg 3.193359375
ulate 0.0008916854858398438
▁blood 1.0224609375
▁pressure 0.0310516357421875
▁and 0.9189453125
▁heart 2.2109375
▁rate 0.1912841796875
, 0.953125
▁potentially 4.68359375
▁benef 3.6171875
iting 0.350830078125
▁women 1.404296875
▁with 0.6171875
▁ob 2.03515625
es 0.0038661956787109375
ity 3.3855438232421875e-05
. 2.94140625
<0x0A> 0.79931640625
N 0.52783203125
or 0.002288818359375
vas 0.00188446044921875
c 0.00015842914581298828
, 0.50341796875
▁a 0.6318359375
▁calci 0.1204833984375
um 3.6835670471191406e-05
▁channel 0.1353759765625
▁block 0.034454345703125
er 0.0019741058349609375
, 0.05096435546875
▁can 1.6455078125
▁also 2.224609375
▁assist 4.0703125
▁in 0.8505859375
▁man 1.8955078125
aging 6.783008575439453e-05
▁men 3.34765625
op 0.0855712890625
aus 0.112060546875
al 0.00017964839935302734
▁sympt 0.07232666015625
oms 0.0010433197021484375
, 1.8447265625
▁but 1.693359375
▁it 1.5859375
▁has 1.5537109375
▁its 4.3046875
▁own 0.25341796875
▁set 0.564453125
▁of 0.00278472900390625
▁potential 1.068359375
▁ris 0.230712890625
ks 1.728534698486328e-05
▁and 0.88427734375
▁benefits 0.2166748046875
. 0.283935546875
▁This 4.65625
▁medic 1.1513671875
ation 0.000789642333984375
▁may 1.787109375
▁lead 3.9375
▁to 0.00846099853515625
▁peri 5.4375
pher 0.00957489013671875
al 0.0005011558532714844
▁ed 0.406494140625
ema 0.006744384765625
▁and 1.4921875
▁fl 4.984375
ushing 0.10809326171875
, 0.5703125
▁which 2.05859375
▁can 1.09375
▁be 1.228515625
▁particularly 3.615234375
▁problem 1.771484375
atic 0.0007081031799316406
▁for 0.39599609375
▁individuals 3.41015625
▁with 0.2666015625
▁ob 1.634765625
es 0.003753662109375
ity 3.421306610107422e-05
. 0.53173828125
▁Moreover 4.1953125
, 0.0004279613494873047
▁Nor 1.21875
vas 0.0008363723754882812
c 0.0003724098205566406
▁usage 5.76171875
▁is 2.17578125
▁generally 4.34375
▁not 2.609375
▁linked 5.3046875
▁to 0.0643310546875
▁an 0.96923828125
▁increased 0.1617431640625
▁risk 0.06219482421875
▁of 0.072509765625
▁breast 0.1435546875
▁cancer 0.01043701171875
. 0.55712890625
▁However 1.771484375
, 0.0014390945434570312
▁given 6.74609375
▁the 1.0771484375
▁pre 3.927734375
dis 0.214599609375
position 0.063232421875
▁to 1.1279296875
▁breast 0.262451171875
▁cancer 0.0087890625
▁in 0.6865234375
▁this 3.73828125
▁scenario 8.140625
, 0.055145263671875
▁its 4.36328125
▁potential 2.08203125
▁benefits 0.56494140625
▁may 1.236328125
▁be 1.5341796875
▁out 1.625
we 0.0157012939453125
ighed 0.004608154296875
▁by 0.040069580078125
▁associated 4.76171875
▁ris 0.1302490234375
ks 6.759166717529297e-05
. 0.103271484375
<0x0A> 0.1044921875
D 4.50390625
iet 0.76708984375
▁and 0.41650390625
▁Sm 0.13623046875
oking 0.0008397102355957031
▁Consider 6.3046875
ations 0.0292510986328125
▁in 4.26953125
▁Tre 1.703125
at 0.6943359375
ment 0.00678253173828125
: 1.6435546875
<0x0A> 0.9912109375
Cons 4.42578125
ider 0.3837890625
ing 1.05859375
▁the 0.54296875
▁impact 5.3125
▁of 0.481689453125
▁di 1.1767578125
et 0.00612640380859375
▁and 0.2265625
▁sm 0.03564453125
oking 0.00016617774963378906
▁on 0.31787109375
▁the 1.0673828125
▁treatment 1.421875
▁plan 0.896484375
▁is 4.140625
▁cru 1.9326171875
cial 0.0026645660400390625
▁for 1.822265625
▁optim 3.35546875
izing 0.05682373046875
▁its 4.75
▁effect 1.888671875
iveness 0.01548004150390625
▁and 1.90234375
▁reducing 1.8837890625
▁potential 1.90234375
▁ris 0.51318359375
ks 5.6862831115722656e-05
. 0.32666015625
▁Con 6.38671875
current 3.087890625
ly 1.2529296875
, 0.0261688232421875
▁these 4.05859375
▁l 4.05078125
ifest 2.7894973754882812e-05
yle 0.00193023681640625
▁factors 1.033203125
▁may 1.853515625
▁also 1.0849609375
▁serve 2.8671875
▁as 0.262939453125
▁risk 3.890625
▁mod 5.5
ifiers 0.018890380859375
▁for 1.146484375
▁both 4.61328125
▁ob 6.20703125
es 0.10711669921875
ity 0.0007410049438476562
▁and 0.362060546875
▁breast 0.80419921875
▁cancer 0.007022857666015625
. 0.36376953125
▁Health 7.9453125
care 0.136474609375
▁prov 0.2147216796875
iders 3.254413604736328e-05
▁should 0.73486328125
▁pay 4.48828125
▁careful 2.59765625
▁attention 0.03143310546875
▁to 0.035308837890625
▁the 1.4609375
▁following 1.6572265625
▁consider 2.353515625
ations 6.878376007080078e-05
: 1.6923828125
<0x0A> 0.00921630859375
1 4.37890625
. 0.1771240234375
▁Diet 1.4111328125
: 1.8623046875
<0x0A> 0.94873046875
N 4.98046875
ut 0.366455078125
r 0.1961669921875
itional 0.5810546875
▁choices 5.0234375
▁can 1.9287109375
▁prof 5.0390625
ound 0.0007266998291015625
ly 0.0003745555877685547
▁influence 1.2724609375
▁h 5.0
orm 6.449222564697266e-05
onal 0.833984375
▁im 3.6328125
bal 0.00041413307189941406
ances 0.160400390625
▁and 1.0517578125
▁ob 4.68359375
es 0.0032215118408203125
ity 0.001750946044921875
, 2.197265625
▁which 1.9716796875
▁are 2.138671875
▁intr 6.16796875
ins 1.1923828125
ically 3.230571746826172e-05
▁inter 4.0078125
tw 0.50244140625
ined 0.0006079673767089844
▁with 2.83984375
▁prem 3.341796875
ature 0.004680633544921875
▁men 0.0101318359375
op 0.0009584426879882812
ause 0.0035858154296875
▁sympt 4.1640625
oms 0.01178741455078125
. 0.2177734375
▁Enc 9.015625
ou 0.0149383544921875
rag 0.0212554931640625
ing 0.16064453125
▁a 1.9580078125
▁bal 3.115234375
anced 0.00021445751190185547
▁di 0.2337646484375
et 0.0002465248107910156
▁rich 2.740234375
▁in 0.0047454833984375
▁f 1.4287109375
ruits 0.0025424957275390625
, 0.430908203125
▁veget 0.06903076171875
ables 0.0020580291748046875
, 0.0283050537109375
▁lean 2.947265625
▁prote 1.36328125
ins 3.2901763916015625e-05
, 0.049560546875
▁and 0.328125
▁whole 2.21875
▁gra 0.0504150390625
ins 0.004398345947265625
▁can 0.99609375
▁help 1.091796875
▁support 3.701171875
▁weight 2.845703125
▁management 1.8740234375
▁and 0.77880859375
▁h 3.048828125
orm 0.00029349327087402344
onal 0.49267578125
▁stability 4.3125
. 0.344970703125
▁This 3.7734375
▁may 1.8447265625
▁have 5.04296875
▁a 0.8203125
▁positive 1.091796875
▁impact 0.412353515625
▁on 0.0428466796875
▁sympt 3.3671875
om 1.158203125
▁sever 1.98828125
ity 0.001499176025390625
▁and 0.96142578125
▁overall 2.462890625
▁health 1.208984375
▁out 2.76953125
comes 0.0144500732421875
. 0.374267578125
<0x0A> 0.422607421875
2 0.47314453125
. 0.0014791488647460938
▁Sm 0.05291748046875
oking 0.0009927749633789062
: 0.2666015625
<0x0A> 0.01132965087890625
Sm 1.1962890625
oking 0.07281494140625
▁has 2.306640625
▁been 0.3408203125
▁associated 2.0
▁with 0.004756927490234375
▁an 1.439453125
▁increased 0.098876953125
▁risk 0.044708251953125
▁of 0.07403564453125
▁both 3.51171875
▁ob 0.79638671875
es 0.00033545494079589844
ity 1.0848045349121094e-05
▁and 0.05535888671875
▁breast 0.1439208984375
▁cancer 0.0022716522216796875
. 0.478271484375
▁Address 8.3671875
ing 0.003662109375
▁sm 1.8681640625
oking 0.00252532958984375
▁c 1.4375
ess 0.01323699951171875
ation 0.00013267993927001953
▁is 2.208984375
▁cru 1.701171875
cial 0.0012922286987304688
▁when 3.2890625
▁developing 5.3125
▁a 0.392578125
▁compreh 1.1865234375
ensive 0.00020515918731689453
▁treatment 0.1715087890625
▁plan 0.0433349609375
▁for 0.87109375
▁these 2.873046875
▁middle 9.3125
- 0.043670654296875
aged 0.00836944580078125
▁women 0.0682373046875
. 0.85205078125
▁Health 3.703125
care 0.01519775390625
▁prov 0.08551025390625
iders 5.364418029785156e-06
▁should 0.408447265625
▁offer 3.626953125
▁support 1.9013671875
▁in 2.27734375
▁qu 1.3359375
itting 0.0006051063537597656
▁sm 0.88525390625
oking 0.0016689300537109375
, 1.154296875
▁as 1.767578125
▁it 2.77734375
▁may 1.5185546875
▁help 1.8447265625
▁alle 1.708984375
vi 0.00010335445404052734
ate 0.0006151199340820312
▁sympt 1.091796875
oms 0.0789794921875
, 2.626953125
▁enh 4.09765625
ance 0.0010385513305664062
▁card 4.55859375
i 0.074951171875
ov 0.037109375
asc 7.450580596923828e-05
ular 6.794929504394531e-06
▁health 0.2008056640625
, 0.018310546875
▁and 0.12091064453125
▁lower 3.46484375
▁the 0.493896484375
▁risk 0.134765625
▁of 0.06744384765625
▁breast 1.400390625
▁cancer 0.01074981689453125
. 0.447265625
<0x0A> 0.244384765625
Con 3.4765625
clusion 0.83447265625
: 0.32177734375
<0x0A> 5.046875
In 3.16015625
▁tre 6.71875
ating 7.414817810058594e-05
▁prem 1.310546875
ature 0.00113677978515625
▁men 0.0274505615234375
op 0.00010716915130615234
ause 0.00562286376953125
▁sympt 1.0927734375
oms 0.0024204254150390625
▁in 0.6669921875
▁middle 0.267822265625
- 0.01129913330078125
aged 0.0027751922607421875
▁women 0.0218963623046875
▁with 0.18505859375
▁ob 0.03839111328125
es 0.00017452239990234375
ity 4.172325134277344e-06
▁and 0.1329345703125
▁a 0.0282135009765625
▁pre 0.009613037109375
dis 0.0005536079406738281
position 0.0006132125854492188
▁to 0.0134735107421875
▁breast 0.0038013458251953125
▁cancer 0.0007176399230957031
, 0.021240234375
▁the 2.02734375
▁choice 3.892578125
▁between 1.306640625
▁Met 0.12347412109375
op 0.005657196044921875
rol 0.00021004676818847656
ol 3.0040740966796875e-05
▁and 0.12139892578125
▁Nor 0.008209228515625
vas 0.0006608963012695312
c 0.00012040138244628906
▁must 2.63671875
▁be 0.1368408203125
▁carefully 1.3017578125
▁considered 0.67041015625
, 3.978515625
▁we 4.19140625
igh 0.1185302734375
ing 0.00024008750915527344
▁ris 3.865234375
ks 0.00012505054473876953
▁and 0.1270751953125
▁benefits 0.032012939453125
. 0.7607421875
▁Additionally 3.767578125
, 0.0008821487426757812
▁custom 10.203125
ized 0.97705078125
▁treatment 0.85205078125
▁plans 0.32080078125
▁should 0.97705078125
▁include 2.857421875
▁a 2.240234375
▁focus 2.431640625
▁on 0.0026645660400390625
▁health 3.056640625
y 0.10595703125
▁di 0.5595703125
et 0.0301055908203125
ary 2.830078125
▁choices 0.87158203125
▁and 0.424560546875
▁sm 0.7265625
oking 0.0003502368927001953
▁c 0.0060882568359375
ess 1.537799835205078e-05
ation 9.21487808227539e-05
▁to 2.21875
▁optimize 1.9013671875
▁out 1.77734375
comes 0.0002465248107910156
, 4.1015625
▁manage 5.44140625
▁ob 5.5390625
es 0.0037860870361328125
ity 5.1856040954589844e-05
- 2.4921875
related 0.400634765625
▁concerns 6.7578125
, 0.0290985107421875
▁and 0.032318115234375
▁reduce 1.212890625
▁the 0.39794921875
▁risk 0.2005615234375
▁of 0.039459228515625
▁breast 0.4296875
▁cancer 0.003704071044921875
. 0.160888671875
▁By 4.98828125
▁address 2.611328125
ing 3.0875205993652344e-05
▁both 2.314453125
▁medic 7.7578125
ation 0.294189453125
▁consider 4.5390625
ations 6.949901580810547e-05
▁and 0.1302490234375
▁l 0.85205078125
ifest 8.344650268554688e-07
yle 0.00038933753967285156
▁modifications 2.244140625
, 0.1650390625
▁health 0.40087890625
care 0.00904083251953125
▁prov 0.10943603515625
iders 6.198883056640625e-06
▁can 0.330078125
▁provide 2.79296875
▁compreh 2.94921875
ensive 0.0006241798400878906
▁care 1.2158203125
▁to 1.236328125
▁enh 6.68359375
ance 0.00020253658294677734
▁the 1.30078125
▁quality 1.6875
▁of 0.03125
▁life 0.0310821533203125
▁for 0.359619140625
▁these 1.037109375
▁patients 2.359375
. 0.2001953125
